The Supreme Court on Monday adjourned its hearing in a plea seeking directions to further reduce the qualifying percentile criteria across categories published on March 12, 2022 by the National Board of Examination more than what was reduced for NEET-PG 2020 on July 14, 2020, to accommodate the mitigating and extenuating circumstances that were unique to the candidates who had appeared in NEET-PG 2021, owing to Covid-19.
The Delhi High Court bench headed by Justice Vipin Sanghi observed, “…it has not been examined, as to how the Gautam Gambhir Foundation could have procured the drug Fabiflu from the license dealers/retailers between 22.04.2021 and 29.04.2021.”